Internal Medicine, Hematology & Oncology · Daytona Beach, FL
NPI
1861627663
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
303 N Clyde Morris Blvd
Daytona Beach, FL, 32114
Phone (386) 254-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
890 services
Medicare patients, 2024
306
Average age 76
Drug cost, 2024
$3.2M
2,017 prescriptions
Company payments, 2025
$61.56
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zafar Latif was code 99214 (office e&m - established), 448 times for 143 patients. In total Zafar Latif billed 890 services in 14 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 448 | 143 | $70.09 | $31K |
| 99213 Office E&M - Established | Office | 268 | 177 | $44.42 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 20 | $61.26 | $2,205 |
| 99205 Office E&M - New | Office | 31 | 31 | $129.85 | $4,026 |
| 99223 Hospital E&M - Initial | Facility | 27 | 27 | $134.73 | $3,638 |
| 99222 Hospital E&M - Initial | Facility | 22 | 21 | $102.03 | $2,245 |
| 99204 Office E&M - New | Office | 14 | 14 | $99.16 | $1,388 |
| 99215 Office E&M - Established | Office | 11 | 11 | $103.49 | $1,138 |
By year: 2022 $78K for 1,101 services; 2023 $69K for 985 services; 2024 $60K for 890 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zafar Latif prescribed most often to Medicare patients was Eliquis (Apixaban), with 150 prescriptions and refills. In total Zafar Latif wrote 2,017 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 150 | 215 | 36 | $119K |
| Ondansetron Odt Ondansetron | 84 | 84 | 44 | $1,347 |
| Oxycodone Hcl Generic | 79 | 79 | 29 | $1,079 |
| Levothyroxine Sodium Generic | 69 | 128 | 16 | $547 |
| Anastrozole Generic | 64 | 175 | 19 | $1,070 |
| Potassium Chloride Generic | 60 | 92 | 21 | $1,343 |
| Prochlorperazine Maleate Generic | 60 | 60 | 29 | $594 |
| Gabapentin Generic | 56 | 70 | 18 | $551 |
| Prednisone Generic | 52 | 60 | 30 | $292 |
| Exemestane Generic | 50 | 108 | 12 | $4,607 |
| Ibandronate Sodium Generic | 46 | 134 | 15 | $957 |
| Acyclovir Generic | 38 | 75 | Under 11 | $451 |
| Bicalutamide Generic | 36 | 80 | 12 | $1,042 |
| Calquence Acalabrutinib Maleate | 35 | 35 | Under 11 | $562K |
| Furosemide Generic | 35 | 59 | 14 | $253 |
Brand drugs: - claims; generic drugs: 1,526 claims; opioid claims: 163.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zafar Latif $61.56 ($61.56 in general payments such as food, travel and fees) from 2 companies. The largest payer was BeOne Medicines USA, Inc. with $33.93.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.